{"organizations": [], "uuid": "bf16e9ba8fe8ef81824b2e850b14a99aacbfc660", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-emerald-health-announces-15-millio/brief-emerald-health-announces-15-million-prospectus-sale-idUSFWN1OY0EP", "country": "US", "domain_rank": 408, "title": "BRIEF-Emerald Health Announces $15 Million Prospectus Sale", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-03T15:08:00.000+02:00", "replies_count": 0, "uuid": "bf16e9ba8fe8ef81824b2e850b14a99aacbfc660"}, "author": "", "url": "https://www.reuters.com/article/brief-emerald-health-announces-15-millio/brief-emerald-health-announces-15-million-prospectus-sale-idUSFWN1OY0EP", "ord_in_thread": 0, "title": "BRIEF-Emerald Health Announces $15 Million Prospectus Sale", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-emerald health", "sentiment": "negative"}, {"name": "million prospectus sale reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "reuters) - emerald health therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 08 PM / Updated 14 minutes ago BRIEF-Emerald Health Announces $15 Million Prospectus Sale Reuters Staff \nJan 3 (Reuters) - Emerald Health Therapeutics Inc: \n* EMERALD HEALTH ANNOUNCES $15 MILLION PROSPECTUS SALE; CONCURRENT SECONDARY SALE \n* EMERALD HEALTH THERAPEUTICS- INVESTOR AGREED, SUBJECT TO CERTAIN CUSTOMARY CONDITIONS, TO PURCHASE 3 MILLION UNITS OF COAT A PRICE OF $5.00 PER UNIT \n* EMERALD HEALTH THERAPEUTICS INC - INTENDS TO USE NET PROCEEDS OF OFFERING FOR PRODUCTION AND RESEARCH AND DEVELOPMENT-RELATED GROWTH PLANS \n* EMERALD HEALTH THERAPEUTICS- ALSO AGREED TO PURCHASE FROM EMERALD HEALTH SCIENCES, CONTROL PERSON OF CO, 2 MILLION SHARES HELD BY SCIENCES AT OF $5/SHARE Source text for Eikon:  ", "external_links": [], "published": "2018-01-03T15:08:00.000+02:00", "crawled": "2018-01-03T15:29:04.018+02:00", "highlightTitle": ""}